Skycell
Skycell AG, headquartered in Switzerland (CH), is a leading player in the pharmaceutical logistics industry, specialising in temperature-controlled solutions for the transportation of sensitive medical products. Founded in 2013, Skycell has rapidly established itself as a pioneer in the field, focusing on the unique challenges of shipping biopharmaceuticals and vaccines across global markets. With a strong operational presence in Europe, Asia, and North America, Skycell offers innovative products such as its advanced Skycell containers, which utilise cutting-edge technology to ensure optimal temperature management during transit. This commitment to quality and reliability has positioned Skycell as a trusted partner for major pharmaceutical companies, earning accolades for its contributions to enhancing supply chain efficiency and product integrity.
DitchCarbon Score
How does Skycell's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Skycell's score of 9 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Skycell's reported carbon emissions
In 2022, Skycell reported a significant reduction in its carbon emissions, with total emissions amounting to approximately 36,000 kg CO2e. This marks a substantial decrease from 2021, where emissions were about 2,010,000 kg CO2e, and from 2020, which saw emissions of around 1,695,000 kg CO2e. The drastic drop in emissions in 2022 indicates a strong commitment to sustainability and effective implementation of reduction strategies. Skycell has set ambitious targets to further reduce its greenhouse gas emissions. The company aims to achieve a 42% reduction in absolute Scope 1 and Scope 2 emissions by 2030, using 2020 as the baseline year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. Additionally, Skycell is committed to measuring and reducing its Scope 3 emissions, which encompass indirect emissions in its value chain. Overall, Skycell's proactive approach to climate commitments and its impressive reduction in emissions reflect its dedication to environmental responsibility and sustainability within the pharmaceuticals, biotechnology, and life sciences sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Skycell is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
